dimethyl fumarate
biogen
[]
from the #ectrims late-breaking session: in the 87-patient arise study, treatment with dimethyl fumarate resulted in a more than 80% reduction in risk of first demyelinating event relative to placebo. 
Managing editor, @Neurology_Live ??  host #MindMoments podcast ?? host @medicalwrldnews Deep Dive ?? ??:mhoffman(at)neurologylive(dot)com